Keywords: Biology, Models, Methods, PET/MR
Motivation: Tumor acidosis is a key biomarker for diagnosing cancer and monitoring treatment response. Non-invasive techniques for measuring tumor extracellular pH (pHe) are limited and not yet clinically routine.
Goal(s): This study aimed to evaluate a novel approach using simultaneous PET/MRI with 18F and 68Ga based co-agents to accurately measure tumor pHe.
Approach: We synthesized pH-sensitive 68Ga and 18F PET/MRI co-agents and measured tumor pHe in a metastatic breast cancer mouse model with pre- and post-bicarbonate treatment.
Results: Both agents successfully measured pHe with promising accuracy. The 18F co-agents demonstrated higher precision, with results closely matching those from gold-standard pH sensors.
Impact: This dual PET/MRI approach provides a reliable, non-invasive method for measuring tumor pHe, potentially transforming how tumor acidosis is monitored. It could lead to earlier, more accurate assessments of treatment response, enhancing personalized cancer therapy strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords